CXCL12 and Alzheimer disease: To the best of our knowledge, this is the first study comparing CSF levels of CXCL12, CX3CL1, and YKL-40 with markers of synaptic disturbance, such as Ng, NPTXR, and classical neurochemical AD biomarkers in subjects with early stages of dementia.